Pre-made Panobacumab benchmark antibody ( Whole mAb, anti-Serotype IATS O11 therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Panobacumab biosimilar, Whole Mab: Anti-Serotype IATS O11 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against Pseudomonas aeruginosa.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	List Price(In USD)	Discount off	Discount Price
GMP-Bios-ab-427-1mg	1mg	3090	Inquiry	Inquiry

Size： 1mg | 10mg | 100mg

Description

Products Name (INN Index)	Pre-Made Panobacumab biosimilar, Whole Mab: Anti-Serotype IATS O11 therapeutic antibody
INN Name	Panobacumab
Target	Serotype IATS O11
Format	Whole mAb
Derivation	Human
Species Reactivity	Human
CH1 Isotype	IgM
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-II
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2008
Year Recommended	2009
Companies	Berna Biotech;Aridis Pharmaceuticals
Conditions Approved	na
Conditions Active	Nosocomial pneumonia
Conditions Discontinued	na
Development Tech	na